Car-T Therapy

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business 🔮 fades

Bristol Myers Squibb shares rise following successful Phase 2 trial results for its blood cancer cell therapy, Arlocabtagene Autoleucel.

5 sources 5 articles v 3 2h ago

\n \n \n

\n \n \n \n